title: Evaluation of coeliac disease serological markers in Down syndrome patients.
abstract: BACKGROUND
  The increased incidence of coeliac disease in patients with Down syndrome makes screening of coeliac disease in this population advisable.
  
  
  OBJECTIVE
  Evaluation of efficiency of different serological markers to detect coeliac disease in Down syndrome patients.
  
  
  METHODS
  A total of 56 Down syndrome patients (aged: 1-17 years) were included in study.
  
  
  METHODS
  Patients were evaluated for both IgG and IgA anti-transglutaminase antibodies and for anti-gliadin IgA and IgG antibodies using either purified omega-gliadin, wheat ethanol extract or commercial gliadin. Patients who had at least one positive result were evaluated for antiendomysium antibodies using either monkey oesophagus or human umbilical cord by indirect immunofluorescence. Coeliac disease was diagnosed by typical histological changes on duodenal mucosa.
  
  
  RESULTS
  Increased levels of at least one anti-gliadin IgA and IgG antibody marker were found in 27 out of 56 cases (26 for IgG and 9 for IgA). 11/56 were positive for IgG anti-transglutaminase antibodies and two of them were also positive for IgA anti-transglutaminase antibodies and anti-endomysium antibodies. These two patients were finally diagnosed as coeliacs. Gliadin antigenic fractions employed produced differences in the performance of the anti-gliadin IgA and IgG antibody test. The use of commercial gliadin or wheat ethanol extract showed low sensitivity in IgA anti-gliadin IgA and IgG antibody determination, whereas good sensitivity and specificity were observed with omega-gliadins. IgG anti-transglutaminase antibodies showed a high proportion of false positive results (9 out of 56), whereas anti-endomysium antibodies and IgA anti-transglutaminase antibodies presented an excellent correlation with presence of active coeliac disease.
  
  
  CONCLUSIONS
  Two out of 56 Down syndrome patients were diagnosed as coeliacs, corresponding to an incidence of 3.6%. The use of omega-gliadin presented the best efficiency in anti-gliadin IgA and IgG antibody determination whereas IgA anti-transglutaminase antibodies and anti-endomysium antibody determination showed an absolute correlation with presence of active coeliac disease.
authors.affiliation: Cátedra de Immunologia, Facultad de Ciencias Exactas, UNLP, La Plata, Argentina.
authors.forename: M
authors.initials: M
authors.lastname: Rumbo
authors.forename: F G
authors.initials: FG
authors.lastname: Chirdo
authors.forename: R
authors.initials: R
authors.lastname: Ben
authors.forename: I
authors.initials: I
authors.lastname: Saldungaray
authors.forename: R
authors.initials: R
authors.lastname: Villalobos
mesh_terms: D000293:Adolescent; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002446:Celiac Disease / Q000175:diagnosis* / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D004314:Down Syndrome / Q000150:complications*; D005260:Female; D005903:Gliadin / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007223:Infant; D008297:Male; D011237:Predictive Value of Tests; D011503:Transglutaminases / Q000276:immunology
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D005903:Gliadin; D011503:Transglutaminases